SCHEMBL4280076

SCHEMBL4280076

CS(=O)(=N[SiH3])c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.46
PSIP1 O75475 1/20 0.44
ALDH1A1 P00352 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CA12 O43570 1/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
PLA2G7 Q13093 1/20 0.42
CA9 Q16790 1/20 0.42
CA13 Q8N1Q1 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18838428 0.78 CA1 (0.50) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL2178308 0.78 HTR6 (0.48) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL486788 0.78 HTR6 (0.48) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL2178473 0.78 HTR6 (0.48) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL27971051 0.76 ALDH1A1 (0.48) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL26961003 0.76 HTR6 (0.46) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL20082065 0.76 HTR6 (0.46) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL24862825 0.74 BRD4 (0.47) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL11144542 0.73 PSIP1 (0.52) HTR6PSIP1ALDH1A1CA1CA2
SCHEMBL835147 0.73 ALDH1A1 (0.44) HTR6PSIP1ALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090196906-A1 Kinase inhibitors ALLERGAN, INC. 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090196906-A1 Kinase inhibitors PTK2, MAP3K6, MAP3K20 HTR6 1429/4885PSIP1 3229/4885ALDH1A1 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.